C67.5

Case	Control
129	460076

Location	SNP	Gene	Ref>Alt	Alt in Case	Alt in Control	Chi-square	P-value	Odds Ratio
chr9:103768114	rs117097156	-	A>G	19	19445	34.6	4.048e-09	3.689
chr9:93354595	rs117795896	-	C>T	22	25717	31.48	2.015e-08	3.25
chr7:50218523	rs80248311	-	T>C	12	9872	31.27	2.243e-08	4.508
chr9:93341095	rs117131019	-	G>A	20	23058	29.72	4.99e-08	3.305
chr9:93266717	rs73650484	-	T>C	23	30375	26.11	3.232e-07	2.896
chr13:25710667	rs17081816	-	C>T	55	104830	25.88	3.64e-07	2.119
chr17:80923546	rs75439108	B3GNTL1	G>A	13	12742	25.44	4.561e-07	3.794
chr3:68550882	rs115998075	TAFA1	G>A	12	11363	25.11	5.424e-07	3.95
chr4:120112159	rs78027302	-	G>A	13	12914	24.83	6.267e-07	3.74
chr4:57217223	rs76873627	AASDH	G>A	23	31043	24.4	7.823e-07	2.803
chr4:43170837	rs113685017	-	C>T	18	21520	24.37	7.967e-07	3.131
chr18:5454131	rs79844984	EPB41L3	C>T	21	27659	23.48	1.261e-06	2.863
chr4:57215969	rs61978622	AASDH	C>T	22	30116	22.73	1.86e-06	2.763
chr7:49916006	rs113308315	VWC2	T>C	11	10533	22.49	2.111e-06	3.876
chr1:4724134	rs77390929	AJAP1	A>G	55	111381	21.73	3.136e-06	1.996
chr16:71449362	rs79236769	-	G>T	33	54917	21.61	3.348e-06	2.313
chr2:68410388	rs75521359	AC017083.3	T>C	23	32951	21.48	3.572e-06	2.643
chr17:76534817	rs9892181	DNAH17	C>G	14	15719	21.39	3.745e-06	3.31
chr12:100236005	rs117579597	ANKS1B	T>G	20	27110	20.96	4.692e-06	2.772
chr14:68315877	rs34513318	RAD51B	G>A	14	15968	20.74	5.254e-06	3.256
chr9:103768114	rs117097156	-	A>G	19	18976	35.76	2.23e-09	3.768
chr23:4564207	rs73448070	-	G>T	11	11356	34.01	5.481e-09	5.161
chr9:93354595	rs117795896	-	C>T	22	25353	32.01	1.534e-08	3.288
chr23:4609418	rs6639033	-	G>A	18	26677	31.13	2.407e-08	3.713
chr9:93341095	rs117131019	-	G>A	20	22764	30.18	3.947e-08	3.34
chr3:68550882	rs115998075	TAFA1	G>A	12	10989	26.56	2.55e-07	4.094
chr5:20820304	rs146651435	-	T>C	13	12360	26.47	2.682e-07	3.889
chr7:50218523	rs80248311	-	T>C	11	9553	26.0	3.421e-07	4.235
chr17:80923546	rs75439108	B3GNTL1	G>A	13	12629	25.57	4.264e-07	3.811
chr5:20787690	rs4866062	-	A>G	13	12630	25.55	4.304e-07	3.81
chr4:120112159	rs78027302	-	G>A	13	12717	25.24	5.065e-07	3.782
chr9:93266717	rs73650484	-	T>C	22	28783	25.16	5.279e-07	2.908
chr4:43170837	rs113685017	-	C>T	18	21071	25.11	5.411e-07	3.187
chr4:57217223	rs76873627	AASDH	G>A	22	28537	25.08	5.504e-07	2.903
chr13:25710667	rs17081816	-	C>T	53	99773	24.86	6.18e-07	2.118
chr4:57215969	rs61978622	AASDH	C>T	22	28814	24.72	6.646e-07	2.882
chr18:5454131	rs79844984	EPB41L3	C>T	21	27032	24.36	8.005e-07	2.921
chr8:16733791	rs80035838	-	T>C	28	41276	24.33	8.111e-07	2.589
chr2:3686001	rs11123567	COLEC11	A>G	9	7537	23.0	1.618e-06	4.431
chr23:140950659	rs189490156	MAGEC3	G>A	9	10460	22.69	1.906e-06	4.471

Location

SNP

Gene

Ref>Alt

Alt in Case

Alt in Control

Chi-square

P-value

Odds Ratio

chr9:103768114

rs117097156

-

A>G

19

19445

34.6

4.048e-09

3.689

chr9:93354595

rs117795896

-

C>T

22

25717

31.48

2.015e-08

3.25

chr7:50218523

rs80248311

-

T>C

12

9872

31.27

2.243e-08

4.508

chr9:93341095

rs117131019

-

G>A

20

23058

29.72

4.99e-08

3.305

chr9:93266717

rs73650484

-

T>C

23

30375

26.11

3.232e-07

2.896

chr13:25710667

rs17081816

-

C>T

55

104830

25.88

3.64e-07

2.119

chr17:80923546

rs75439108

B3GNTL1

G>A

13

12742

25.44

4.561e-07

3.794

chr3:68550882

rs115998075

TAFA1

G>A

12

11363

25.11

5.424e-07

3.95

chr4:120112159

rs78027302

-

G>A

13

12914

24.83

6.267e-07

3.74

chr4:57217223

rs76873627

AASDH

G>A

23

31043

24.4

7.823e-07

2.803

chr4:43170837

rs113685017

-

C>T

18

21520

24.37

7.967e-07

3.131

chr18:5454131

rs79844984

EPB41L3

C>T

21

27659

23.48

1.261e-06

2.863

chr4:57215969

rs61978622

AASDH

C>T

22

30116

22.73

1.86e-06

2.763

chr7:49916006

rs113308315

VWC2

T>C

11

10533

22.49

2.111e-06

3.876

chr1:4724134

rs77390929

AJAP1

A>G

55

111381

21.73

3.136e-06

1.996

chr16:71449362

rs79236769

-

G>T

33

54917

21.61

3.348e-06

2.313

chr2:68410388

rs75521359

AC017083.3

T>C

23

32951

21.48

3.572e-06

2.643

chr17:76534817

rs9892181

DNAH17

C>G

14

15719

21.39

3.745e-06

3.31

chr12:100236005

rs117579597

ANKS1B

T>G

20

27110

20.96

4.692e-06

2.772

chr14:68315877

rs34513318

RAD51B

G>A

14

15968

20.74

5.254e-06

3.256

chr9:103768114

rs117097156

-

A>G

19

18976

35.76

2.23e-09

3.768

chr23:4564207

rs73448070

-

G>T

11

11356

34.01

5.481e-09

5.161

chr9:93354595

rs117795896

-

C>T

22

25353

32.01

1.534e-08

3.288

chr23:4609418

rs6639033

-

G>A

18

26677

31.13

2.407e-08

3.713

chr9:93341095

rs117131019

-

G>A

20

22764

30.18

3.947e-08

3.34

chr3:68550882

rs115998075

TAFA1

G>A

12

10989

26.56

2.55e-07

4.094

chr5:20820304

rs146651435

-

T>C

13

12360

26.47

2.682e-07

3.889

chr7:50218523

rs80248311

-

T>C

11

9553

26.0

3.421e-07

4.235

chr17:80923546

rs75439108

B3GNTL1

G>A

13

12629

25.57

4.264e-07

3.811

chr5:20787690

rs4866062

-

A>G

13

12630

25.55

4.304e-07

3.81

chr4:120112159

rs78027302

-

G>A

13

12717

25.24

5.065e-07

3.782

chr9:93266717

rs73650484

-

T>C

22

28783

25.16

5.279e-07

2.908

chr4:43170837

rs113685017

-

C>T

18

21071

25.11

5.411e-07

3.187

chr4:57217223

rs76873627

AASDH

G>A

22

28537

25.08

5.504e-07

2.903

chr13:25710667

rs17081816

-

C>T

53

99773

24.86

6.18e-07

2.118

chr4:57215969

rs61978622

AASDH

C>T

22

28814

24.72

6.646e-07

2.882

chr18:5454131

rs79844984

EPB41L3

C>T

21

27032

24.36

8.005e-07

2.921

chr8:16733791

rs80035838

-

T>C

28

41276

24.33

8.111e-07

2.589

chr2:3686001

rs11123567

COLEC11

A>G

9

7537

23.0

1.618e-06

4.431

chr23:140950659

rs189490156

MAGEC3

G>A

9

10460

22.69

1.906e-06

4.471

ID	Name	Top Correlation
HP: 0000009	Functional abnormality of the bladder	0/20
HP: 0000014	Abnormality of the bladder	0/20
HP: 0000020	Urinary incontinence	0/20
HP: 0000032	Abnormality of male external genitalia	0/20
HP: 0000036	Abnormality of the penis	0/20
HP: 0000078	Abnormality of the genital system	0/20
HP: 0000079	Abnormality of the urinary system	0/20
HP: 0000080	Abnormality of reproductive system physiology	0/20
HP: 0000118	Phenotypic abnormality	0/20
HP: 0000119	Abnormality of the genitourinary system	0/20
HP: 0000795	Abnormality of the urethra	0/20
HP: 0000811	Abnormal external genitalia	0/20
HP: 0002836	Bladder exstrophy	0/20
HP: 0004298	Abnormality of the abdominal wall	0/20
HP: 0010461	Abnormality of the male genitalia	0/20
HP: 0010936	Abnormality of the lower urinary tract	0/20
HP: 0010992	Stress urinary incontinence	0/20
HP: 0011277	Abnormality of the urinary system physiology	0/20
HP: 0012243	Abnormal reproductive system morphology	0/20
HP: 0012874	Abnormal male reproductive system physiology	0/20
HP: 0012875	Abnormal ejaculation	0/20
HP: 0012877	Retrograde ejaculation	0/20
HP: 0025031	Abnormality of the digestive system	0/20
HP: 0025142	Constitutional symptom	0/20
HP: 0025487	Abnormality of bladder morphology	0/20
HP: 0031058	Impairment of activities of daily living	0/20
HP: 0031064	Impaired continence	0/20
HP: 0032076	Abnormal male urethral meatus morphology	0/20
HP: 0100548	Exstrophy	0/20
HP: 0100627	Displacement of the urethral meatus	0/20

Bladder neck

C67.5

Case/Control GWAS ^ⓘ

Links

Statistics

Top SNP Information

Associated Phenotypes ^ⓘ

Bladder neck

C67.5

Case/Control GWAS ⓘ

Links

Statistics

Top SNP Information Show Table

Associated Phenotypes ⓘ Shared SNP phenotypes No shared SNP phenotypes

Case/Control GWAS ^ⓘ

Top SNP Information

Associated Phenotypes ^ⓘ